Publications
Publications
Show Results For
-
All HBS Web
(7,989)
- Faculty Publications (1,301)
Page 1 of
1,301
Results
→
Are you looking for?
Background
Primary care practices have experienced major strains during the COVID-19 pandemic, such that patients newly seeking care may face...
Primary care practices have experienced major strains during the COVID-19 pandemic, such that patients newly seeking care may face...
Gilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the...
- July 2021
- Case
Fynd
By: Ranjay Gulati, Kairavi Dey and Rachna Tahilyani
Fynd is a fast-growing venture that in 7 years since its founding has become India's largest omnichannel retail company with real-time access to over 9,000 stores' offline inventory. It started as a B2B business supporting retailers who didn’t have an online business,...
View Details
- July 2021
- Case
Brigham & Women’s Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care
By: Robert S. Kaplan, Navraj S. Nagra and Syed S. Shehab
Dr. Andrea Pusic, breast cancer reconstruction surgeon, wants to extend outcomes measurement beyond traditional surgical metrics of infections, complications, and survival rates. The case describes her development of a new mobile phone app, which collects patients’...
View Details
- 2021
- Working Paper
Do Policies to Increase Access to Treatment for Opioid Use Disorder Work?
By: Eric Barrette, Leemore S. Dafny and Karen Shen
As of 2016 there were an estimated 2.1 million Americans suffering from opioid use disorder (OUD). To date, most policy interventions have focused on curbing opioid prescriptions and extending insurance coverage to include substance use disorder. However, relatively...
View Details
- July 2021
- Case
Kevin D. Johnson: To Be a Venture Capitalist or an Operator?
By: Jo Tango and Alys Ferragamo
In May of 2021, Kevin D. Johnson had just graduated from a rigorous Executive MBA program, and he quickly needed to decide on his next career move. Johnson was the founder and CEO of a successful media company, Johnson Media Inc., but his career goals had shifted while...
View Details
Keywords:
United States
- July 2021
- Article
Making Medications Stick: Improving Medication Adherence by Highlighting the Personal Health Costs of Non-compliance
By: Jon M. Jachimowicz, Joe J. Gladstone, Dan Berry, Charlotte L. Kirkdale, Tracey Thornley and Adam D. Galinsky
Poor compliance of prescription medication is an ongoing public health crisis. Nearly half of patients do not take their medication as prescribed, harming their own health while also increasing public health care costs. Despite these detrimental consequences, prior...
View Details
- July 2021
- Article
Medical Debt in the U.S., 2009–2020
By: Ray Kluender, Neale Mahoney, Francis Wong and Wesley Yin
Importance: Medical debt is an increasing concern in the US, yet there is limited understanding of the amount and distribution of medical debt, and its association with health care policies.
Objective: To measure the amount of medical debt nationally and by... View Details
Objective: To measure the amount of medical debt nationally and by... View Details
- 2021
- Article
Regulatory, Legal, and Market Aspects of Smart Wearables for Cardiac Monitoring
By: Jan Benedikt Brönneke, Jennifer Müller, Konstantinos Mouratis, Julia Hagen and Ariel Dora Stern
In the area of cardiac monitoring, the use of digitally driven technologies is on the rise. While the development of medical products is advancing rapidly, allowing for new use-cases in cardiac monitoring and other areas, regulatory and legal requirements that govern...
View Details
- 2021
- Working Paper
Accounting for Product Impact in the Pharmaceuticals Industry
By: Amanda Rischbieth, George Serafeim and Katie Trinh
We apply the product impact measurement framework of the Impact-Weighted Accounts Initiative (IWAI) in two competitor companies within the pharmaceuticals industry. We design a monetization methodology that allows us to calculate monetary impact estimates of accessible...
View Details
Keywords:
Product Innovation;
Impact;
Impact Investing;
Impact Measurement;
ESG;
ESG (Environmental, Social, Governance) Performance;
ESG Ratings;
Social Corporate Responsibility;
Corporate Social Responsibility;
Social Impact;
Pharmaceutical Companies;
Pharmaceuticals;
Product Design;
Product Positioning;
Society;
Environmental Sustainability;
Corporate Social Responsibility and Impact;
Product;
Safety;
Pharmaceutical Industry
- June 2021
- Teaching Note
Michael Phelps: 'It’s Okay to Not Be Okay'
By: Boris Groysberg, Carin-Isabel Knoop and Michael Norris
Teaching Note for HBS Case No. 421-044. In 2020, Michael Phelps, the most decorated Olympian of all time, with 28 medals in various swimming events, was now retired. As he looked back on his 20+ year athletic career, he considered what had gone into making him the...
View Details
- June 2021
- Case
CFM International (A): Building a Durable Partnership That Works
By: Ranjay Gulati, Yves Doz, Kim Wilkinson and Kerry Herman
It is spring 1995, and the CFM partnership—a joint venture between GE Aviation and France’s jet engine manufacturer Snecma—is facing difficult challenges. The parent companies must decide whether and how to renew their nascent partnership agreement, in the face of...
View Details
- June 15, 2021
- Article
Cutting the Gordian Knot of Employee Health Care Benefits and Costs: A Corporate Model Built on Employee Choice
By: Regina E. Herzlinger and Barak D. Richman
President Joe Biden’s promise to give every American access to affordable health insurance is well-intentioned, but his plan’s policy elements—a public option, a permanent expanded tax credit—require congressional approval and would expend significant political and...
View Details
- June 11, 2021
- Article
Addressing Demographic Disparities in Clinical Trials
By: Kathy Giusti, Richard G. Hamermesh and Mark Krasnow
Disparities in health care are not just limited to the delivery of care. They also exist in the way that clinical trials are structured. Women, people of color, and the elderly often are not adequately represented. This article offers three strategies for addressing...
View Details
- June 10, 2021
- Article
Preparing Hospitals for the Next Pandemic
By: Regina E. Herzlinger and Barak D. Richman
The COVID-19 epidemic response has shown that the U.S. is blessed with heroic physicians and other health care providers, researchers, and facilities. But it has also revealed a health care system that was woefully unprepared for the surge of pandemic patients. In the...
View Details
- June 2, 2021
- Article
The CMS New Rule on Ambulatory Surgical Centers Earns Only Partial Credit
By: Junaid Nabi and Robert S. Kaplan
The Centers of Medicare and Medicaid Services (CMS) recently announced that it will be removing more...
View Details
- June 2021
- Case
Akira Fukabori and Kevin Kajitani at avatarin (A)
By: Linda A. Hill and Emily Tedards
In 2016, Akira Fukabori and Kevin Kajitani, aeronautical engineers at All Nippon Airways Co., Ltd., began to wonder why, in a world of accelerating globalization and digital connectivity, those who lived in far-remote villages or impoverished urban areas could not...
View Details
Keywords:
Agility;
Ecosystem;
Innovation Ecosystems;
Crowdsourcing;
Open Innovation;
Partnership;
Government;
Collaboration;
Co-creation;
Purpose;
Impact;
Social Impact;
Movement;
Organizational Behavior;
Organizational Ambidexterity;
Ambidexterity;
Culture;
Culture Change;
Global Teams;
Experimentation;
Space;
Airline Industry;
Start-up;
Platform Business;
Platform Strategy;
Platform;
Digital;
Robotics;
Robots;
Mobility;
Strategy;
COVID-19;
Intrapreneurship;
Public-private Partnership;
XPRIZE;
Space Industry;
Avatar;
Telepresence;
Innovation Lab;
Innovation and Invention;
Technological Innovation;
Partners and Partnerships;
Collaborative Innovation and Invention;
Alignment;
Leadership;
Leading Change;
Diversity;
Organizational Culture;
Change Management;
Entrepreneurship;
Transportation Industry;
Aerospace Industry;
Japan
- June 2021
- Case
Akira Fukabori and Kevin Kajitani at avatarin (A) (Abridged)
By: Linda A. Hill and Emily Tedards
In 2016, Akira Fukabori and Kevin Kajitani, aeronautical engineers at All Nippon Airways Co., Ltd., began to wonder why, in a world of accelerating globalization and digital connectivity, those who lived in far-remote villages or impoverished urban areas could not...
View Details
Keywords:
Agility;
Ecosystem;
Innovation Ecosystems;
Innovation;
Crowdsourcing;
XPRIZE;
Open Innovation;
Partnership;
Government;
Collaboration;
Co-creation;
Purpose;
Impact;
Social Impact;
Movement;
Organizational Behavior;
Organizational Ambidexterity;
Ambidexterity;
Culture;
Culture Change;
Global Teams;
Experimentation;
Space;
Space Industry;
Airline Industry;
Start-up;
Platform Business;
Platform Strategy;
Platform;
Digital;
Robotics;
Robots;
Avatar;
Telepresence;
Innovation Lab;
Mobility;
COVID-19;
Intrapreneurship;
Public-private Partnership;
Innovation and Invention;
Technological Innovation;
Partners and Partnerships;
Collaborative Innovation and Invention;
Alignment;
Leadership;
Leading Change;
Diversity;
Organizational Culture;
Change Management;
Strategy;
Entrepreneurship;
Transportation Industry;
Aerospace Industry;
Japan
- June, 2021
- Article
Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users
By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt
Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling...
View Details
- June 2021
- Article
Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care Initiative
By: Casey J. Allen, Jarrod S. Eska, Nikhil G. Thaker, Thomas W. Feeley, Robert S. Kaplan, Ryan W. Huey, Ching-Wei D. Tzeng, Jeffrey E. Lee, Steven J. Frank, Thomas A. Aloia, Vijaya Gottumukkala and Matthew H.G. Katz
We used national administrative data to assess multiple domains of value associated with enhanced recovery pathways for patients undergoing pancreatic surgery. Value metrics included in-hospital mortality, complication rates, length of stay (LOS), 30-day readmission...
View Details
- June 2021
- Article
The Covid-19 Pandemic Should Not Delay Actions to Prevent Anticompetitive Consolidation in U.S. Health Care Markets
By: Leemore S. Dafny
This article describes potential regulatory and legislative reforms to assist antitrust enforcement agencies in halting anticompetitive acquisitions and practices, and preserving and promoting competition in health care markets.
View Details
- May 2021
- Case
Inclusive Innovation at Mass General Brigham
By: Katherine Baldiga Coffman and Olivia Hull
Massachusetts General Brigham (MGB) Chief Innovation Officer Christopher Coburn had overseen a period of exciting transformation and growth in healthcare innovation at MGB. In November 2019, the health system was the largest recipient of National Institutes of Health...
View Details
Keywords:
Inclusion;
Innovation;
Invention;
Gender;
Business Startups;
Investment Funds;
Private Equity;
Health Care and Treatment;
Innovation Strategy;
Technological Innovation;
Intellectual Property;
Copyright;
Patents;
Research;
Research and Development;
Diversification;
Technology;
Health Industry;
Massachusetts;
Boston